APA (7th ed.) Citation

Qiu, J., Cao, L., Bi, S., Han, P., Wang, Z., & Klug, Y. A. (2026). SREBP2 as a Novel Biomarker for Posttransplant Hepatocellular Carcinoma Recurrence: A New Prognostic Nomogram. BioMed Research International, 2026, 1. https://doi.org/10.1155/bmri/4309464

Chicago Style (17th ed.) Citation

Qiu, Jiali, Lei Cao, Sensheng Bi, Pengyu Han, Zhenglu Wang, and Yoel A. Klug. "SREBP2 as a Novel Biomarker for Posttransplant Hepatocellular Carcinoma Recurrence: A New Prognostic Nomogram." BioMed Research International 2026 (2026): 1. https://doi.org/10.1155/bmri/4309464.

MLA (9th ed.) Citation

Qiu, Jiali, et al. "SREBP2 as a Novel Biomarker for Posttransplant Hepatocellular Carcinoma Recurrence: A New Prognostic Nomogram." BioMed Research International, vol. 2026, 2026, p. 1, https://doi.org/10.1155/bmri/4309464.